Atea Pharmaceuticals, Inc. (AVIR) vs Strata Critical Medical, Inc. (SRTA)

A side-by-side comparison of Atea Pharmaceuticals, Inc. and Strata Critical Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVIR vs SRTA

growth of $100 · dividends reinvested · last 6y
AVIR -83.1% (-25.6%/yr)SRTA -51.8% (-11.4%/yr)SRTA compounded faster over this window
0100200300Start $100202120222023202420252026$17$48
AVIR SRTA

AVIR vs SRTA: by the numbers

  • •SRTA is the larger company ($411M vs $404M market cap).
  • •SRTA is profitable (15.71% net margin) while AVIR runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAVIRSRTA
P/E ratioN/A9.55
P/S ratioN/A1.61
P/B ratio1.981.47

Profitability

MetricAVIRSRTA
Gross margin0.00%20.56%
Operating margin0.00%-7.97%
Net margin0.00%15.71%
ROE-80.96%14.40%
ROIC-89.93%-7.11%

Growth (annualized)

MetricAVIRSRTA
Revenue CAGR (5Y)N/A46.05%
Total return CAGR (5Y)-34.44%-13.77%

Frequently asked

Is AVIR or SRTA more profitable?
SRTA runs the higher net margin — AVIR at 0.00% versus SRTA at 15.71%.
How have AVIR and SRTA total returns compared?
Over the past 5 years, AVIR delivered -34.44% and SRTA delivered -13.77% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.